135 related articles for article (PubMed ID: 11293095)
1. [PASS neurocognitive dysfunction in attention deficit].
Pérez-Alvarez F; Timoneda-Gallart C
Rev Neurol; 2001 Jan 1-15; 32(1):30-7. PubMed ID: 11293095
[TBL] [Abstract][Full Text] [Related]
2. [The hyperkinetic patient in the light of PASS theory].
Pérez-Alvarez F; Timoneda C
Rev Neurol; 1999 Mar 1-15; 28(5):472-5. PubMed ID: 10229959
[TBL] [Abstract][Full Text] [Related]
3. [Dyslexia as a disfunction in successive processing].
Pérez-Alvarez F; Timoneda-Gallart C
Rev Neurol; 2000 Apr 1-15; 30(7):614-9. PubMed ID: 10859738
[TBL] [Abstract][Full Text] [Related]
4. Cognitive versus behavioral ADHD phenotype: what is it all about?
Perez-Alvarez F; Serra-Amaya C; Timoneda-Gallart CA
Neuropediatrics; 2009 Feb; 40(1):32-8. PubMed ID: 19639526
[TBL] [Abstract][Full Text] [Related]
5. [Dysphasia and dyslexia in the light of PASS theory].
Pérez-Alvarez F; Timoneda C
Rev Neurol; 1999 Apr 1-15; 28(7):688-93. PubMed ID: 10363295
[TBL] [Abstract][Full Text] [Related]
6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
7. [Cognitive aspects of attention deficit hyperactivity disorder in children].
Cupello S
Rev Prat; 2002 Nov; 52(18):2005-8. PubMed ID: 12602166
[TBL] [Abstract][Full Text] [Related]
8. [Cognitive functions, their development and modern diagnostic methods].
Klasik A; Janas-Kozik M; Krupka-Matuszczyk I; Augustyniak E
Przegl Lek; 2006; 63 Suppl 1():29-34. PubMed ID: 17471820
[TBL] [Abstract][Full Text] [Related]
9. [Different verbal behavior in children with attention deficit between 7 and 12 years of age].
Pineda DA; Restrepo MA; Henao GC; Gutiérrez-Clellen V; Sánchez D
Rev Neurol; 1999 Dec 16-31; 29(12):1117-27. PubMed ID: 10652733
[TBL] [Abstract][Full Text] [Related]
10. Disentangling weak coherence and executive dysfunction: planning drawing in autism and attention-deficit/hyperactivity disorder.
Booth R; Charlton R; Hughes C; Happé F
Philos Trans R Soc Lond B Biol Sci; 2003 Feb; 358(1430):387-92. PubMed ID: 12639335
[TBL] [Abstract][Full Text] [Related]
11. [Behavioural and neuropsychological characteristics of children of both sexes, between 6 and 11 years of age, with attention deficit hyperactivity disorder].
Puentes-Rozo PJ; Barceló-Martínez E; Pineda DA
Rev Neurol; 2008 Aug 16-31; 47(4):175-84. PubMed ID: 18671206
[TBL] [Abstract][Full Text] [Related]
12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
13. [Neurocognitive symptoms of childhood attention deficit hyperactivity disorder].
Szérémi A; Tárnok Z; Farkas L; Dótzi J; Gádoros J
Psychiatr Hung; 2005; 20(4):299-311. PubMed ID: 16462007
[TBL] [Abstract][Full Text] [Related]
14. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
15. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder.
McLean A; Dowson J; Toone B; Young S; Bazanis E; Robbins TW; Sahakian BJ
Psychol Med; 2004 May; 34(4):681-92. PubMed ID: 15099422
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
Barnett R; Maruff P; Vance A
Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
[TBL] [Abstract][Full Text] [Related]
17. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
19. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity].
Mulas F; Roselló B; Morant A; Hernández S; Pitarch I
Rev Neurol; 2002 Jul 1-15; 35(1):17-24. PubMed ID: 12389187
[TBL] [Abstract][Full Text] [Related]
20. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?
Nigg JT; Willcutt EG; Doyle AE; Sonuga-Barke EJ
Biol Psychiatry; 2005 Jun; 57(11):1224-30. PubMed ID: 15949992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
